Cyrus J. Lawrence’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-5,146
Closed -$744K 107
2024
Q4
$744K Sell
5,146
-101
-2% -$15.7K 0.14% 49
2024
Q3
$850K Sell
5,247
-474
-8% -$75.5K 0.17% 48
2024
Q2
$836K Sell
5,721
-527
-8% -$78.4K 0.17% 48
2024
Q1
$988K Buy
+6,248
New +$995K 0.22% 48
2023
Q3
$10.2M Sell
6,579
-45,392
-87% -$7.49M 2.81% 8
2023
Q2
$8.6M Sell
51,971
-752
-1% -$121K 1.86% 14
2023
Q1
$8.17M Sell
52,723
-891
-2% -$144K 2.38% 14
2022
Q4
$9.47M Sell
53,614
-251
-0.5% -$43.3K 2.83% 8
2022
Q3
$8.8M Sell
53,865
-2,623
-5% -$444K 1.73% 15
2022
Q2
$10M Sell
56,488
-412
-0.7% -$73.4K 2.89% 10
2022
Q1
$10.1M Buy
+56,900
New +$9.68M 2.31% 14

Other funds holding JNJ

Cyrus J. Lawrence's JNJ Position: Q1 2025 in Review

Cyrus J. Lawrence sold out of Johnson & Johnson (JNJ) in Q1 2025, closing a stake of 5,146 shares — an estimated $744K sold.

Cyrus J. Lawrence first reported a position in JNJ in Q1 2022 and held it in 11 quarters. The position peaked at $10.2M in Q3 2023. 4,157 funds tracked by Wall St. Rank hold JNJ as of Q1 2025.

  • Cyrus J. Lawrence reported no remaining Johnson & Johnson position as of Q1 2025 after selling out during the quarter.
  • Cyrus J. Lawrence sold 5,146 Johnson & Johnson shares in Q1 2025, an estimated $744K.
  • Cyrus J. Lawrence first reported a position in Johnson & Johnson in Q1 2022 and held it in 11 quarters.
  • Cyrus J. Lawrence's Johnson & Johnson position peaked at $10.2M in Q3 2023.
  • 4,157 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2025.

Based on Cyrus J. Lawrence's 13F filing for Q1 2025, filed 15 May 2025.